Concept rendering of PLPC-DB?, a non-cellular oncology immunotherapy platform. Lyophilized formulation stable at room temperature for 18+ months. ORLANDO, Fla., September 3, 2025 (Newswire.com) - OGRD ...
ORLANDO, FL / ACCESS Newswire / September 3, 2025 / OGRD Alliance introduces PLPC-DB™, a next-generation, non-cellular oncology immunotherapy platform now entering a global acquisition window. Unlike ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback